BBNX: Mensinger Mike discloses a sale
By AlphaYouPublished Form 4
Mensinger Mike
Reporting filer
Mensinger Mike reported Sale in Beta Bionics, Inc.: 2650 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 17, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Mensinger Mike | 2026-09-16 | S | Sale | 2650 | 22 | 177,390 | 1 day | Filed terms
|
Common Stock
- Owner
- Mensinger Mike
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 2650
- Price
- 22
- Following holdings
- 177,390
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2650
- transaction Price Per Share: 22
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 177390
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Mensinger Mike: Chief Product Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.